Filing Details
- Accession Number:
- 0001415889-24-023609
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-18 16:15:14
- Reporting Period:
- 2024-09-16
- Accepted Time:
- 2024-09-18 16:15:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1953926 | Zenas Biopharma Inc. | ZBIO | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1953107 | Enavate Sciences Gp, Llc | 2882 Sand Hill Road, Suite 100 Menlo Park CA 94025 | No | No | No | No | |
2037042 | Zebra Aggregator, Lp | 106 West 56Th Street, 8Th Floor New York NY 10019 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-09-16 | 2,879,006 | $0.00 | 2,879,006 | No | 4 | C | Indirect | By Zebra Aggregator, LP |
Common Stock | Acquisiton | 2024-09-16 | 882,353 | $17.00 | 3,761,359 | No | 4 | P | Indirect | By Zebra Aggregator, LP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | By Zebra Aggregator, LP |
No | 4 | P | Indirect | By Zebra Aggregator, LP |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series B Preferred Stock | Disposition | 2024-09-16 | 10,474,889 | $0.00 | 1,206,353 | $0.00 |
Common Stock | Series C Preferred Stock | Disposition | 2024-09-16 | 14,523,821 | $0.00 | 1,672,653 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- Each share of Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") converted into shares of Common Stock of the Issuer on an 8.6831-for-one basis without payment of further consideration. Immediately prior to the closing of the Issuer's initial public offering, the Preferred Stock was converted into the number of shares of Common Stock of the Issuer shown in column 7 of Table II. The Preferred Stock has no expiration date.
- Shares are directly held by Zebra Aggregator, LP ("Zebra"). Enavate Sciences GP, LLC ("Enavate") is the general partner of Zebra and may be deemed to share voting and investment power with respect to the shares held by Zebra. Enavate disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.